Biological
rV-Tricom clinical trials
- studies test it
- 4
- open now
- 0
- in phase 3
- 0
- first study started
- 2001
How studies write it
Studies that test it under each name
Studies by the year they started
4 studies that test it; most in 2001 (1)
| Year | Studies |
|---|---|
| 2001 | 1 |
| 2003 | 1 |
| 2006 | 1 |
| 2007 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 2
- Phase 2
- 2
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 0 · Other 4
National Cancer Institute (NCI) (3) · Herbert Irving Comprehensive Cancer Center (1)
Often tested with
Tested in the same studies.
Sargramostim (1) · Recombinant Fowlpox-TRICOM Vaccine (1) · Rilimogene glafolivec (1)
Studies
Open first, then newest update. How each study uses rV-Tricom is read from its arms, and is right about nine times in ten.
Testing it · 4
- 153Sm-EDTMP With or Without a PSA/TRICOM Vaccine To Treat Men With Androgen-Insensitive Prostate CancerCompletedPhase 2National Cancer Institute (NCI)NCT00450619Written as Recombinant vaccinia-TRICOM vaccine
- A Phase II Study of PROSTVAC-V (Vaccinia)/TRICOM and PROSTVAC-F (Fowlpox)/TRICOM With GM-CSF in Patients With PSA Progression After Local Therapy for Prostate CancerCompletedPhase 2National Cancer Institute (NCI)NCT00108732Written as Recombinant Vaccinia-TRICOM Vaccine
- Vaccine Therapy in Treating Patients With Metastatic MelanomaStatus unknownPhase 1Herbert Irving Comprehensive Cancer CenterNCT00022568Written as recombinant vaccinia-TRICOM vaccine
- Vaccine Therapy in Treating Patients With Metastatic Breast CancerTerminatedPhase 1National Cancer Institute (NCI)NCT00071942Written as recombinant vaccinia-TRICOM vaccine